Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:4139596.
doi: 10.1155/2016/4139596. Epub 2016 Feb 28.

Impact of Additional Transthoracic Electrical Cardioversion on Cardiac Function and Atrial Fibrillation Recurrence in Patients with Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation

Deguo Wang  1 , Fengxiang Zhang  2 , Ancai Wang  1
Affiliations

Impact of Additional Transthoracic Electrical Cardioversion on Cardiac Function and Atrial Fibrillation Recurrence in Patients with Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation

Deguo Wang et al. Cardiol Res Pract. 2016.

Abstract

Backgrounds and Objective. During the procession of radiofrequency catheter ablation (RFCA) in persistent atrial fibrillation (AF), transthoracic electrical cardioversion (ECV) is required to terminate AF. The purpose of this study was to determine the impact of additional ECV on cardiac function and recurrence of AF. Methods and Results. Persistent AF patients received extensive encircling pulmonary vein isolation (PVI) and additional line ablation. Patients were divided into two groups based on whether they need transthoracic electrical cardioversion to terminate AF: electrical cardioversion (ECV group) and nonelectrical cardioversion (NECV group). Among 111 subjects, 35 patients were returned to sinus rhythm after ablation by ECV (ECV group) and 76 patients had AF termination after the ablation processions (NECV group). During the 12-month follow-ups, the recurrence ratio of patients was comparable in ECV group (15/35) and NECV group (34/76) (44.14% versus 44.74%, P = 0.853). Although left atrial diameters (LAD) decreased significantly in both groups, there were no significant differences in LAD and left ventricular cardiac function between ECV group and NECV group. Conclusions. This study revealed that ECV has no significant impact on the maintenance of SR and the recovery of cardiac function. Therefore, ECV could be applied safely to recover SR during the procedure of catheter ablation of persistent atrial fibrillation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The three-dimensional diagram of catheter ablation persistent atrial fibrillation and myocardial biomarkers. Representative circumferential pulmonary vein isolation and additional ablation line on an electroanatomic map (a). Cardiac function by echocardiography (b). LAD: left atrial diameter. LVEDd: left ventricle diastolic end diameter. LVEDs: left ventricle systolic end diameter. LVEF: left ventricle ejection fraction. ∗ P < 0.01 versus pre-CA (before catheter ablation).
See this image and copyright information in PMC

References

    1. Kannel W. B., Wolf P. A., Benjamin E. J., et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. American Journal of Cardiology. 1998;82(8) - PubMed
    1. Weerasooriya R., Jaïs P., Hocini M., et al. Effect of catheter ablation on quality of life of patients with paroxysmal atrial fibrillation. Heart Rhythm. 2005;2(6):619–623. doi: 10.1016/j.hrthm.2005.02.1037. - DOI - PubMed
    1. Lutomsky B. A., Rostock T., Koops A., et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace. 2008;10(5):593–599. doi: 10.1093/europace/eun076. - DOI - PubMed
    1. Lin H.-J., Wolf P. A., Kelly-Hayes M., et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke. 1996;27(10):1760–1764. doi: 10.1161/01.str.27.10.1760. - DOI - PubMed
    1. Van Gelder I. C., Crijns H. J. G. M., Tieleman R. G., et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Archives of Internal Medicine. 1996;156(22):2585–2592. doi: 10.1001/archinte.156.22.2585. - DOI - PubMed

LinkOut - more resources